[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342931-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-342931-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","exploration-of-the-prognostic-value-of-methylation-regulators-related-to-m5c-in-papillary-thyroid-carcinoma","Exploration of the prognostic value of methylation regulators related to m5C in papillary thyroid carcinoma","","Incidence of papillary thyroid carcinoma (PTC) has risen, and for metastatic or recurrent cases current treatment options remain insufficient because the molecular basis of PTC is not fully clarified. This study investigates 5-methylcytosine (m5C) RNA methylation and identifies ten m5C regulators with distinct expression patterns. Immune infiltration shows negative correlations between most regulators and regulatory T cells; TRDMT1, NSUN5, and NSUN6 contribute strongly to protein–protein interactions. Differential genes from TCGA are enriched in cancer-related pathways, and NSUN2, NSUN4, NSUN6, and DNMT3B form prognostic markers.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/exploration-of-the-prognostic-value-of-methylation-regulators-related-to-m5c-in-papillary-thyroid-carcinoma/342931/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/exploration-of-the-prognostic-value-of-methylation-regulators-related-to-m5c-in-papillary-thyroid-carcinoma/342931.png","ImageObject",300,407,{"name":42,"@type":43},"Maeve","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-02","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What problem does the study address in papillary thyroid carcinoma (PTC)?","Question",{"text":62,"@type":63},"The study addresses the lack of fully understood molecular mechanisms in PTC and the insufficient treatment options for metastatic and recurrent patients.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"How are m5C methylation regulators used in this research?",{"text":67,"@type":63},"Ten m5C regulators with significantly different expression levels are analyzed, and four regulators (NSUN2, NSUN4, NSUN6, DNMT3B) are screened as prognostic markers to build predictive models.",{"name":69,"@type":60,"acceptedAnswer":70},"Which m5C regulators are identified as risk factors and what is the model’s performance focus?",{"text":71,"@type":63},"NSUN2 and NSUN6 are identified as risk factors for poor prognosis. The multi-factor prognostic prediction model shows stronger prognostic predictive power, with best prediction for 5-year survival.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},342931,1790125062,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","®  \n Diagnostic Accuracy Study   \nExploration of the prognostic value of methylation regulators related to m5C in papillary thyroid carcinoma  \nFurong Nie, MMeda , Jiacheng Jiang, MDb , Jie Ning, PhDa ,*  \n\n| Abstract\u003Cbr>The incidence of papillary thyroid carcinoma (PTC) has increased significantly in recent years, and for patients with metastatic andrecurrent PTC, the options for treatment currently available are insufficient. To date, the exact molecular mechanism underlying PTC is still not fully understood. 5-Methylcytosine (m5C) RNA methylation is associated with the prognosis of a variety of tumors. However, the molecular mechanisms and biomarkers associated with m5C in the diagnosis, treatment, and prognosis of this disease have not been fully elucidated. Ten m5C regulators with significantly different expression levels were included in this study. Immune infiltration analysis revealed significant negative correlations between most of these regulators and regulatory T cells. TRDMT1, NSUN5, and NSUN6 had high weights and strong correlations in the protein–protein interaction network. Using gene ontology, Kyoto Encyclopedia of Genes and Genomes, and gene set enrichment analysis, 1489 differentially expressed genes were screened from The Cancer Genome Atlas messenger RNA matrix, indicating that these differentially expressed genes were significantly enriched in various pathways and functions related to cancers. Four m5C regulators, NSUN2, NSUN4, NSUN6, and DNMT3B, were screened as prognostic markers by least absolute shrinkage and selection operator regression analysis, and NSUN2 and NSUN6 were identified as risk factors for poor prognosis. We found that the prognostic prediction model constructed using the m5C regulators NSUN2, NSUN4, NSUN6, and DNMT3B showed good prognostic prediction ability and diagnostic ability. This model was applied to predict the survival probability of patients with PTC, the prediction ability of 5-year survival was the best. The multi-factor prognostic prediction model combined with the tumor node metastasis stage and risk score grouping showed better prognostic predictive power. |\n| --- |\n| Abbreviations: BP = biological process, CC = cellular components, DEG = differentially expressed gene, GEO = Gene Expression Omnibus, GO = gene ontology, GSEA = gene set enrichment analysis, KEGG = Kyoto Encyclopedia of Genes and Genomes, LASSO = least absolute shrinkage and selection operator, MF = molecular function, PPI = protein–protein interaction, PTC = papillary thyroid carcinoma, ROC = receiver operating characteristic, RS = risk score, TCGA = The Cancer Genome Atlas. |\n| Keywords: m5C methylation, papillary thyroid carcinoma, prognostic risk model |\n\n1. Introduction  \nThyroid carcinoma is one of the most common endocrine system malignancies,[1] and its incidence has increased in recent years.[2] Papillary thyroid carcinoma (PTC) accounts for 80% to 85% for the whole thyroid cancer.[3,4] For PTC with welldifferentiated and low invasion into adjacent tissues, through surgical resection and treatment with radioactive iodine, most patients have a good prognosis, with a satisfactory overall treatment effect[5] and a 5-year survival rate exceedings 95% .[6] Recurrence, metastasis, and even death affect 20% to 30% of  \npatients.[7] Currently, ultrasonic examination is the most preferred diagnostic method for PTC, however, due to the subjective cognitive level of examining doctors, high-resolution ultrasound examination is currently the preferred diagnostic method. However, there are some overlaps in malignant and benign nodules in the ultrasonic features, with great differences in the interpretation and recommendations of clinical sonographers based on these features.[7] Thus, there is no gold standard for diagnosing PTC and predicting its prognosis. Many cases of PTC are misdiagnosed or missed, leading to overtreatment and delayed treatment. Molecular biomarkers used in the diagnosis  \nFN and JJ contribut","cbCaitCH3M9MrLUy","https://ap.wps.com/l/cbCaitCH3M9MrLUy","pdf",3964932,14,"English","# Abstract\n# Abbreviations\n# Introduction","[{\"question\":\"What problem does the study address in papillary thyroid carcinoma (PTC)?\",\"answer\":\"The study addresses the lack of fully understood molecular mechanisms in PTC and the insufficient treatment options for metastatic and recurrent patients.\"},{\"question\":\"How are m5C methylation regulators used in this research?\",\"answer\":\"Ten m5C regulators with significantly different expression levels are analyzed, and four regulators (NSUN2, NSUN4, NSUN6, DNMT3B) are screened as prognostic markers to build predictive models.\"},{\"question\":\"Which m5C regulators are identified as risk factors and what is the model’s performance focus?\",\"answer\":\"NSUN2 and NSUN6 are identified as risk factors for poor prognosis. The multi-factor prognostic prediction model shows stronger prognostic predictive power, with best prediction for 5-year survival.\"}]","Exploration of the prognostic value of methylation regulators related to m5C in papillary thyroid carcinoma | PDF",1790048886,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2410b5caee5caf622a7702587fbfe3a1.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43c6bb55075d20a09fdb173ed2eb9a82.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee98272bdc8fbb0d1029270e557191ab.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4fc79f1ee52d9c5c63ec824f621ee6ac.webp",980,1306]